Le Lézard
Classified in: Health, Business
Subject: SCZ

Fidelis Care Announces Partnership With National Council On Aging To Prevent Falls Among Seniors


REGO PARK, N.Y., Nov. 20, 2019 /PRNewswire/ -- Fidelis Care announces a partnership with the National Council on Aging (NCOA) to help prevent falls among Medicare Advantage beneficiaries.

Fidelis Care Earns NCQA Health Plan Accreditation (PRNewsfoto/Fidelis Care)

Falls are a leading cause of injury for people aged 65 and older and can threaten their safety and independence, as well as generate great economic and personal hardships. However, through evidence-based falls prevention programs and partnerships between organizations like Fidelis Care and NCOA, the number of falls among older adults can be substantially reduced.

"Research shows that older adults living with chronic conditions such as diabetes, heart failure, poor oral health, hearing loss and vision loss are at a greater risk for falls. Fidelis Care is pleased to partner with NCOA to help address risk factors and educate our Medicare Advantage beneficiaries on ways to prevent falls," said Dr. Vincent Marchello, Chief Medical Officer for Fidelis Care. "Whether it is assessing their homes for fall hazards, educating them on the correct usage of prescription medication or teaching them how being active can reduce fall risks, our program aims to prevent falls and help our older members live healthy lifestyles."

Fidelis Care Medicare Advantage plans have a number of benefits to help members improve or maintain their health, which is critical to preventing falls. For instance, most plans include vision and hearing care, and provide members with a Care Manager to help coordinate their care. "All of these benefits, along with the outreach programs we offer, will help many of our members avoid falls and the consequences that come with them," said Marchello.

Medicare is a government health insurance program for people ages 65 or older. It may also cover certain younger people with disabilities. Medicare beneficiaries can shop for a Fidelis Legacy Plan Medicare Advantage product that meets their healthcare needs and budget during the Annual Enrollment Period through December 7, 2019.

Consumers and their family members can compare products and enroll by visiting fideliscare.org, or by calling 1-800-860-8707 to speak to a licensed Medicare sales representative.

About Fidelis Care:
Fidelis Care is a mission-driven health plan offering quality, affordable coverage for children and adults of all ages and at all stages of life. With more than 1.7 million members Statewide, Fidelis Care believes that all New Yorkers should have access to affordable, quality health insurance. For more information, call Fidelis Care at 1-888-FIDELIS (1-888-343-3547) or visit fideliscare.org.

Follow us on Twitter at @fideliscare and on Facebook at facebook.com/fideliscare.

CONTACT: MediaInquiries@fideliscare.org

SOURCE Fidelis Care


These press releases may also interest you

at 09:15
ACADIA Pharmaceuticals Inc. , today announced that it will present at the Cowen and Company 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, at 2:10 p.m. Eastern Time. A live webcast of ACADIA's presentation will be accessible...

at 09:15
In a landmark legal decision, the Human Rights Tribunal of Ontario has ordered the Ford government to take concrete actions to end the gender pay gap midwives experience as a result of the Ministry of Health's discriminatory actions....

at 09:15
The "Infant Nutrition Market by Product Type Form and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering. According to the report, the global infant nutrition...

at 09:15
Kalsow Plastic Surgery of New York City is exited to announce that its own, Dr. Sergei Kalsow, MD, PC has been awarded his board certification by the American Society of Plastic Surgeons. This prestigious certification is awarded to physicians...

at 09:12
BioInvent International AB (OMXS: BINV) will issue its interim report for the fourth quarter 2019 on Thursday February 27 at 7.30 a.m. CET, followed by an audiocast with teleconference at 8.30 a.m. CET, hosted by Martin Welschof, CEO and members of...

at 09:10
On February 1, the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and OncoImmune, Inc. launched a new Phase II clinical trial called CALIBER, which will test whether OncoImmune's lead product, CD24Fc, can...



News published on 20 november 2019 at 09:00 and distributed by: